These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2851995

  • 21. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
    Vratilova J, Frgala T, Maurer BJ, Patrick Reynolds C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep 05; 808(2):125-30. PubMed ID: 15261805
    [Abstract] [Full Text] [Related]

  • 22. Retinoids inhibit prolactin-induced development of the mammary gland in vitro.
    Mehta RG, Cerny WL, Moon RC.
    Carcinogenesis; 1983 Sep 05; 4(1):23-6. PubMed ID: 6821885
    [Abstract] [Full Text] [Related]

  • 23. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
    Sani BP, Shealy YF, Hill DL.
    Carcinogenesis; 1995 Oct 05; 16(10):2531-4. PubMed ID: 7586162
    [Abstract] [Full Text] [Related]

  • 24. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
    Bunk MJ, Telang NT, Higgins PJ, Traganos F, Sarkar NH.
    Nutr Cancer; 1985 Oct 05; 7(1-2):105-15. PubMed ID: 2999720
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
    Ratko TA, Detrisac CJ, Mehta RG, Kelloff GJ, Moon RC.
    Cancer Res; 1991 Jan 15; 51(2):481-6. PubMed ID: 1824682
    [Abstract] [Full Text] [Related]

  • 26. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM, Plante RK, Visconti V, Lau CY.
    Cancer Res; 1996 Mar 01; 56(5):1056-62. PubMed ID: 8640761
    [Abstract] [Full Text] [Related]

  • 27. N-Nitrosodiethylamine-induced nodule-like alveolar lesion and its prevention by a retinoid in BALB/c mouse mammary glands in the whole organ in culture.
    Chatterjee M, Banerjee MR.
    Carcinogenesis; 1982 Mar 01; 3(7):801-4. PubMed ID: 6214328
    [Abstract] [Full Text] [Related]

  • 28. Retinoids and mammary gland differentiation.
    Moon RC, Mehta RG, McCormick DL.
    Ciba Found Symp; 1985 Mar 01; 113():156-67. PubMed ID: 3896699
    [Abstract] [Full Text] [Related]

  • 29. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
    Swanson BN, Newton DL, Roller PP, Sporn MB.
    J Pharmacol Exp Ther; 1981 Dec 01; 219(3):632-7. PubMed ID: 6170750
    [Abstract] [Full Text] [Related]

  • 30. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
    Welsch CW, DeHoog JV, Moon RC.
    Carcinogenesis; 1984 Oct 01; 5(10):1301-4. PubMed ID: 6237806
    [Abstract] [Full Text] [Related]

  • 31. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Lewis KC, Hochadel JF.
    Cancer Res; 1999 Dec 01; 59(23):5947-55. PubMed ID: 10606240
    [Abstract] [Full Text] [Related]

  • 32. Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland.
    Tu Y, Jerry DJ, Pazik B, Smith Schneider S.
    Mol Cancer Res; 2005 Aug 01; 3(8):435-42. PubMed ID: 16123139
    [Abstract] [Full Text] [Related]

  • 33. Effects of retinoid glucuronides on mammary gland development in organ culture.
    Mehta RG, Barua AB, Olson JA, Moon RC.
    Oncology; 1991 Aug 01; 48(6):505-9. PubMed ID: 1749591
    [Abstract] [Full Text] [Related]

  • 34. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
    McCormick DL, Moon RC.
    Carcinogenesis; 1986 Feb 01; 7(2):193-6. PubMed ID: 2936526
    [Abstract] [Full Text] [Related]

  • 35. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
    Abou-Issa H, Curley RW, Alshafie GA, Weiss KL, Clagett-Dame M, Chapman JS, Mershon SM.
    Anticancer Res; 2001 Feb 01; 21(6A):3839-44. PubMed ID: 11911255
    [Abstract] [Full Text] [Related]

  • 36. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N, Sausville EA, Breitman TR.
    Clin Cancer Res; 1995 Jun 01; 1(6):637-42. PubMed ID: 9816026
    [Abstract] [Full Text] [Related]

  • 37. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B, Tari AM, Mehta K, Lopez-Berestein G.
    Leuk Lymphoma; 2004 May 01; 45(5):979-85. PubMed ID: 15291358
    [Abstract] [Full Text] [Related]

  • 38. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
    Kabbout M, Hatoum A, Abou-Lteif G, Chakroun I, Homaidan FR, Darwiche N.
    Mol Carcinog; 2004 May 01; 40(1):12-23. PubMed ID: 15108326
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse.
    Osborne MP, Telang NT, Kaur S, Bradlow HL.
    Steroids; 1990 Mar 01; 55(3):114-9. PubMed ID: 2139751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.